Literature DB >> 17586371

Retrospective comparison of 3 laser platforms to correct myopic spheres and spherocylinders using conventional and wavefront-guided treatments.

Perry S Binder1, Joseph Rosenshein.   

Abstract

PURPOSE: To compare 3 excimer laser platforms for the correction of myopic spheres and myopic spherocylinders using conventional algorithms or wavefront-guided treatments.
SETTING: Private practice, in-office laser facility.
METHODS: This retrospective comparative interventional case series comprised 458 patients (721 eyes). Sequentially selected patient eyes had laser in situ keratomileusis surgery by the same surgeon using 1 of 3 lasers (Visx Star S4, LADARVision 4000, WaveLight Allegretto) with a conventional algorithm or with wavefront-guided software. The same aberrometer was used before and after surgery in a given eye. A femtosecond laser (IntraLase Corp.) was used for flap creation. Parametric and nonparametric 1-way analysis of variance and regression analysis were performed. Outcomes were analyzed for change in visual, refractive, and wavefront categories.
RESULTS: On average, all lasers improved uncorrected visual acuity and best spectacle-corrected visual acuity, produced predictable refractive change, and induced higher-order aberrations (HOAs). Overall, the Star S4 wavefront treatment improved results compared with Star S4 conventional treatment; however, LADARVision wavefront treatment did not improve the conventional results. The Allegretto produced the best results in the category of visual acuity in spherocylinder eyes only. The Star S4 wavefront treatment produced the best HOA results for sphere and spherocylinder. In the spherocylinder group, the LADARVision reduced astigmatism and defocus the most.
CONCLUSION: These results document that different laser platforms achieve statistically significantly different outcomes depending on refractive, patient, and surgical variables.

Entities:  

Mesh:

Year:  2007        PMID: 17586371     DOI: 10.1016/j.jcrs.2007.03.040

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Aspheric wavefront-guided versus wavefront-guided LASIK for myopic astigmatism with the Technolas 217z100 excimer laser.

Authors:  Suphi Taneri; Saskia Oehler; Scott M MacRae
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-29       Impact factor: 3.117

2.  The SCHWIND AMARIS Total-Tech Laser as An All-Rounder in Refractive Surgery.

Authors:  Maria Clara Arbelaez; Samuel Arba Mosquera
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

3.  Comparison of Wavelight Allegretto Eye-Q and Schwind Amaris 750S excimer laser in treatment of high astigmatism.

Authors:  Maja Bohac; Alma Biscevic; Mateja Koncarevic; Marija Anticic; Nikica Gabric; Sudi Patel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-23       Impact factor: 3.117

4.  Myopic Laser-Assisted Subepithelial Keratectomy (LASEK) outcomes using three different excimer laser platforms: a retrospective observational study.

Authors:  Isabel Rodríguez-Pérez; Juan Gros-Otero; Miguel A Teus; Rafael Cañones; Montserrat García-González
Journal:  BMC Ophthalmol       Date:  2019-10-15       Impact factor: 2.209

5.  Comparison of outcomes of conventional WaveLight(®) Allegretto Wave(®) and Technolas(®) excimer lasers in myopic laser in situ keratomileusis.

Authors:  Daphne Cy Han; Jean Chen; Hla Myint Htoon; Donald Th Tan; Jodhbir S Mehta
Journal:  Clin Ophthalmol       Date:  2012-07-24

6.  Wavefront-guided versus cross-cylinder photorefractive keratectomy in moderate-to-high astigmatism: a cohort of two consecutive clinical trials.

Authors:  M R Sedghipour; R Sorkhabi; A Mostafaei
Journal:  Clin Ophthalmol       Date:  2012-01-31

7.  Visual Outcomes and Higher Order Aberrations Following LASIK on Eyes with Low Myopia and Astigmatism.

Authors:  Smita Agarwal; Erin Thornell; Chris Hodge; Gerard Sutton; Paul Hughes
Journal:  Open Ophthalmol J       Date:  2018-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.